95% CI, 1.12.8) (Park et al., 2023)
Cardoso A
People who take semaglutide or tirzepatide should talk to their physicians if they are concerned about ongoing access to the medications that they need, rather than turning to a product that might not be safe
It's important to contextualize this concern: No published study has shown BPC-157 causing or promoting tumor growth The body already produces BPC-157-related compounds naturally in gastric juice Many foods and supplements (such as curcumin and certain vitamins) also promote angiogenesis without being considered cancer risks The concern remains theoretical, not evidence-based, but it warrants continued research Out of an abundance of caution, we recommend that individuals with active malignancies consult their oncologist before using BPC-157
GLP1-RA treatment-associated decrease in the risk of depression or anxiety in DM patients may be driven by combinations of anti-inflammation, better glycemic control, greater weight loss, and reduced concern about weight gain (Bode et al., 2010)
If CJC 1295 is the one knocking on the door, Ipamorelin is the one that opens the door wide and ensures a strong, clean exit